GB0308603D0 - Pharmaceutical combinations for treating viral infections - Google Patents

Pharmaceutical combinations for treating viral infections

Info

Publication number
GB0308603D0
GB0308603D0 GBGB0308603.0A GB0308603A GB0308603D0 GB 0308603 D0 GB0308603 D0 GB 0308603D0 GB 0308603 A GB0308603 A GB 0308603A GB 0308603 D0 GB0308603 D0 GB 0308603D0
Authority
GB
United Kingdom
Prior art keywords
viral infections
treating viral
pharmaceutical combinations
pharmaceutical
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0308603.0A
Other versions
GB2400552A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to GB0308603A priority Critical patent/GB2400552A/en
Publication of GB0308603D0 publication Critical patent/GB0308603D0/en
Priority to PCT/GB2004/001612 priority patent/WO2004089382A1/en
Priority to CL200401262A priority patent/CL2004001262A1/en
Publication of GB2400552A publication Critical patent/GB2400552A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB0308603A 2003-04-14 2003-04-14 Pharmaceutical combinations for treating viral infections Withdrawn GB2400552A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0308603A GB2400552A (en) 2003-04-14 2003-04-14 Pharmaceutical combinations for treating viral infections
PCT/GB2004/001612 WO2004089382A1 (en) 2003-04-14 2004-04-14 Pharmaceutical combinations comprising lamivudine, zidovudine and efavirenz for treating viral infections
CL200401262A CL2004001262A1 (en) 2003-04-14 2004-05-25 PHARMACEUTICAL COMPOSITION THAT INCLUDES LAMIVUDINE, ZIDOVUDINA AND EFAVIRENZ, OR DERIVATIVES OF THEM; PHARMACEUTICAL KIT; PROCEDURE FOR PREPARATION; AND USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF VIRAL INFECTIONS, AND

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0308603A GB2400552A (en) 2003-04-14 2003-04-14 Pharmaceutical combinations for treating viral infections

Publications (2)

Publication Number Publication Date
GB0308603D0 true GB0308603D0 (en) 2003-05-21
GB2400552A GB2400552A (en) 2004-10-20

Family

ID=9956763

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0308603A Withdrawn GB2400552A (en) 2003-04-14 2003-04-14 Pharmaceutical combinations for treating viral infections

Country Status (3)

Country Link
CL (1) CL2004001262A1 (en)
GB (1) GB2400552A (en)
WO (1) WO2004089382A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110104267A1 (en) * 2005-04-25 2011-05-05 Aurobindo Pharma Limited Pharmaceutical compositions of antiretrovirals
JP2020529461A (en) * 2017-08-09 2020-10-08 ヴィーブ ヘルスケア カンパニー Combinations and their use and treatment
US20200171039A1 (en) * 2017-08-09 2020-06-04 Viiv Healthcare Company Combinations and uses and treatments
CN114392239B (en) * 2022-01-10 2023-06-27 安徽贝克生物制药有限公司 Compound tablet of lamivudine, zidovudine and efavirenz and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003051301A2 (en) * 2001-12-14 2003-06-26 Hemispherx Biopharma USE OF dsRNAs IN STRATEGIC THERAPEUTIC INTERVENTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY

Also Published As

Publication number Publication date
GB2400552A (en) 2004-10-20
CL2004001262A1 (en) 2005-05-06
WO2004089382A1 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
IL174685A0 (en) Nucleoside compounds for treating viral infections
PL380828A1 (en) Phosphoranians, amidomonophosphoranians, amidobisphosphoranians for treating virus diseases
IL184955A0 (en) Tricyclic-nucleoside compounds for treating viral infections
PL376454A1 (en) 1-acyl-pyrrolidine derivatives for the treatment of viral infections
IL174684A0 (en) Nucleoside compounds for treating viral infections
EG27104A (en) Pharmaceutical compounds
EP1594512A4 (en) Compounds for the treatment of viral infection
IL178141A0 (en) Combinations for treating hiv infection
IL173365A0 (en) Piperazine derivatives for the treatment of hiv infections
GB0315657D0 (en) Pharmaceutical compounds
IL203061A (en) Halogenated benzamide compounds for treating viral infections
IL189792A0 (en) Benzodiazepine derivatives for treating hepatitis c infection
HK1095036A1 (en) Virus therapeutic drug
GB0329254D0 (en) Treatment of viral infections
GB0308511D0 (en) Pharmaceutical compounds
GB2411354B (en) Use of Scutellaria for the treatment of viral infections
EP1626692A4 (en) Compounds for the treatment of flaviviridae infections
EP1660116A4 (en) Method of treating viral infections
AU2003303123A8 (en) Dna vaccines against hantavirus infections
GB0317315D0 (en) Pharmaceutical compounds
GB0329958D0 (en) Treatment of viral infections
GB0308603D0 (en) Pharmaceutical combinations for treating viral infections
GB0313766D0 (en) Pharmaceutical compounds
AU2003237088A8 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
GB0301736D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1070813

Country of ref document: HK

WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1070813

Country of ref document: HK